PainTEQ, a leader in minimally invasive solutions for chronic pain, today announced enrollment of the first patient in the TRAQTION Study, a prospective, multicenter clinical study evaluating outcomes ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
NeuraLight, a healthtech company providing precision biomarkers quantifying change in brain function, today announced a new ...
Federally funded research suggests that standardizing what defines contamination could increase accuracy of diagnoses, optimize treatments, avoid unnecessary medications and improve patient outcomes ...